1
/
of
1
CXCR7 modulator 1 [CAS 2231812-31-8]
CXCR7 modulator 1 [CAS 2231812-31-8]
SKU:QM-0112833-01
£664.79 GBP
Quantity
Couldn't load pickup availability
Request quote or documents
![CXCR7 modulator 1 [CAS 2231812-31-8]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
CXCR7 modulator 1 (compound 25) is a potent and orally bioavailable peptoid hybrid CXCR7 modulator, with a Ki of 9 nM[1].
-
CAS Number
[2231812-31-8]
-
Molecular Formula
C48H57F2N7O7S
-
Molecular Weight
914.07
-
Smiles
O=C(N[C@@H](CC(C)(C)C)C(N[C@@H](CC1=CSC=N1)C(N2CCC[C@@H]2C(N(CCCC3=C(F)C=C(F)C=C3)CC4=O)=O)=O)=O)[C@@H](CC5=CC=CC=C5)NC([C@H](COCC6=CC=CC=C6)N4)=O
-
Target
CXCR
-
Isoform
CXCR7
-
Purity
99.5
-
Solubility
DMSO : 250 mg/mL (ultrasonic)
-
Storage Conditions
-20°C (Powder, stored under nitrogen)
-
Shipping Conditions
Blue Ice
Related Products
- QM-0025230 β-catenin inhibitory peptoid [CAS 2579070-02-1]
- QM-0023369 α-Synuclein inhibitor 14 [CAS 408324-13-0]
- QM-0015918 β2AR agonist 5 [CAS 2759727-47-2]
- QM-0015098 α2AR agonist 2 [CAS 719277-27-7]
- QM-0013035 α-Synuclein inhibitor 15 [CAS 414880-30-1]
- QM-0013016 αMβ2 integrin agonist-1
- QM-0013015-01 α5β1 integrin agonist-2
- QM-0013014 α4β1 antagonist-1
- QM-0012730-01 YTHDF2 ligand-1 [CAS 3093182-34-1]
- QM-0009574 α5-GABAA receptor modulator 1
Other industry favorites
- QM-0025230 β-catenin inhibitory peptoid [CAS 2579070-02-1]
- QM-0023369 α-Synuclein inhibitor 14 [CAS 408324-13-0]
- QM-0141339-01 δ-Secretase inhibitor 11 [CAS 842964-18-5]
- QM-0196447-01 α2β1 Integrin Ligand Peptide (TFA)
- QM-0065091 μ opioid receptor agonist 1 [CAS 2667632-83-7]
- QM-0070729 β-Catenin modulator-5 [CAS 902168-07-4]
- QM-0150540-01 β-FXR antagonist 1 [CAS 2295804-92-9]
- QM-0153508-01 α-Synuclein inhibitor 11
- QM-0122210 δ opioid receptor antagonist 1
- QM-0121938 α-Synuclein inhibitor 13
CXCR7 modulator 1 [CAS 2231812-31-8]
CXCR7 modulator 1 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.